Brief: Xbrane Biopharma Q3 EBITDA Loss Narrows To SEK 37.6 Mln

Xbrane Biopharma AB

28/10/2022 07:37

Oct 28 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * Q3 REVENUE AMOUNTED TO SEK 13.9 M (2.3)
    * Q3 EBITDA AMOUNTED TO SEK -37.6 M (-39.5)

Source text for Eikon:  ID:nMFN1Wrpll 
Further company coverage:  XBRANE.ST 
 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))